Welcome to our dedicated page for DELIC HOLDINGS news (Ticker: DELCF), a resource for investors and traders seeking the latest updates and insights on DELIC HOLDINGS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DELIC HOLDINGS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DELIC HOLDINGS's position in the market.
Delic Holding Corp announced that Delic Labs has applied for a Health Canada 56 Research Exemption to research MDMA and LSD, in addition to its current psilocybin research. The lab aims to commercialize its findings and develop pharmaceutical compounds from psychedelic sources. With a Dealer's License application underway, Delic Labs seeks to lead in psychedelic compound safety testing and expand its capabilities. Co-founders emphasized the potential for innovative treatments for conditions like depression and PTSD, reinforcing Delic's commitment to advancing psychedelic wellness.
Delic Holdings Corp has announced that Dr. Molly Maloof will be the keynote speaker at the Meet Delic event, scheduled for November 6-7, 2021, in Las Vegas, Nevada. This immersive experience will focus on the intersection of psychedelics, wellness, and business. Dr. Maloof's presentation will explore the historical and future roles of psychedelics in relationships. The event will feature extensive panels and presentations from industry leaders, aiming to raise awareness of the potential benefits of psychedelics. Tickets are currently available.
Delic Holding Corp has partnered with Paradigm Healthcare to integrate advanced toxicology testing into its Ketamine Infusion Centers. This collaboration utilizes Paradigm's Benchmark UDT™ testing platform, enhancing patient safety by identifying drug interactions and determining ketamine levels for tailored treatments. Over the past three years, KIC has delivered 4,000 treatments and generated over $1.5MM in revenue, expanding from Arizona to California. This partnership aims to improve care for patients with mental health conditions.
Delic Holding Corp (CSE: DELC, OTCQB: DELCF) has partnered with Paradigm Healthcare to enhance the safety and effectiveness of ketamine infusion treatments at Ketamine Infusion Centers (KIC). This collaboration introduces the Benchmark UDT™ toxicology testing platform, enabling the identification of existing drugs in patients and ensuring accurate ketamine levels throughout treatment. KIC has delivered over 4,000 treatments and generated over USD$1.5MM in revenue. The partnership aims to provide personalized care for patients with serious behavioral health conditions.
Delic Holdings Corp. has successfully closed a private placement with a U.S. institutional investor, raising approximately C$7.0 million. The financing involved the issuance of 9,000,000 units and 15,561,404 pre-funded units, with each unit priced at C$0.285 and each pre-funded unit at C$0.2849. The company plans to use the net proceeds to enhance its clinic footprint, cover operating costs, and pursue acquisitions. H.C. Wainwright acted as the exclusive placement agent, receiving a cash commission of approximately $560,000 and compensation warrants.
Lamar Odom, two-time NBA champion, is set to headline Meet Delic in Las Vegas on November 7. The event focuses on psychedelic wellness and will feature Odom discussing his recovery journey highlighted in the documentary Lamar Odom Reborn. This immersive experience will take place at AREA15 and includes keynote speakers, panels, and entertainment, aiming to raise awareness about the benefits of psychedelics. Tickets are available now, and the event promises to foster discussions on mental health and addiction recovery.
Delic Holdings Corp has announced that former NBA star Lamar Odom will be the keynote speaker at the Meet Delic event in Las Vegas on November 7, 2021. Odom will share his personal recovery journey and screen the documentary Lamar Odom Reborn, which details his struggles with addiction and healing through psychedelics. The two-day event will feature discussions, panels, and a psychedelic business expo, aiming to raise awareness about the benefits of psychedelic treatments in addressing mental health issues.
Delic Holdings Corp, a leader in psychedelic wellness, has unveiled the full lineup of speakers for its immersive event, Meet Delic, taking place on November 6-7, 2021, at AREA15 in Las Vegas.
This two-day event features prominent thought leaders, medical experts, and entertainers, emphasizing the growing interest in psychedelics. Attendees can expect panels on various significant topics, live performances, and the largest psychedelic business expo.
Tickets are now available at meetdelic.com.
Delic Holdings Corp (CSE: DELC, OTCQB: DELCF) has revealed the speaker lineup for its upcoming psychedelic wellness event, 'Meet Delic', scheduled for November 6-7, 2021, at AREA15 in Las Vegas. The event will feature prominent figures such as Duncan Trussell, Aubrey Marcus, and Dr. Carl Hart, along with a series of engaging panels on psychedelics and wellness. Attendees can expect live music, visual art, and discussions aimed at making psychedelics accessible to the public. Tickets are currently available for this immersive experience.
Delic Holdings has announced a binding merger agreement with Ketamine Wellness Centers (KWC), positioning itself as the largest psychedelic wellness organization in the U.S. The acquisition includes KWC’s 10 clinics across multiple states and will expand Delic’s operations to a total of 12 locations, with plans for 15 more clinics in the next 18 months. KWC generated over USD$3.5MM in 2020 and is projected to reach USD$4.5MM in 2021. The merger aims to increase accessibility to psychedelic treatments for mental health conditions, leveraging Delic's media and marketing capabilities.
FAQ
What is the market cap of DELIC HOLDINGS (DELCF)?
